Ex vivo cytotoxic drug evaluation by DiSC assay to expedite identification of clinical targets: Results with 8-chloro-cAMP

British Journal of Cancer

Volumn 76, Issue 4, 1997, Pages 511-518

  Bosanquet, A G ^a,c   Burlton, A R ^a   Bell, P B ^a   Harris, A L ^b  

^a UNIVERSITY OF BATH   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

Differential Staining Cytotoxicity assay; Ex vivo cytotoxic drug evaluation; Ex vivo phase II trial; Ex vivo therapeutic index

Indexed keywords

8 CHLOROADENOSINE 3',5' PHOSPHATE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DRUG METABOLITE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHRONIC LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CROSS RESISTANCE; DRUG CYTOTOXICITY; DRUG SCREENING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SOLID TUMOR; STAINING;

EID: 0030760713     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.417     Document Type: Article

References (42)

1. Allsopp MA and Sewell GJ (1995) A pharmacokinetic-pharmacodynamic study on carboplatin administered in prolonged continuous infusion regimens with syncronous radiotherapy. J Oncol Pharm Prac 1: 25-32
2. Borsellino N, Crescimanno M, Leonardo V and D'Alessandro N (1994) Effects of 8-chloro-cyclic adenosine monophosphate on the growth and sensitivity to doxorubicin of multidrug-resistant tumor cell lines. Pharmacol Res 30: 81-90
3. Bosanquet AG (1991) Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay. Lancet 337: 711-714
4. Bosanquet AG (1994) Short-term in vitro drug sensitivity tests for cancer chemotherapy. A summary of correlations of test result with both patient response and survival. Forum Trends Exp Clin Med 4: 179-198
5. Bosanquet AG and Forskitt S (1989) Effect of cell isolation methods and drug concentration on the use of the Differential Staining Cytotoxicity (DiSC) assay with solid tumours. Cytotechnology 2: 225-232
6. Bosanquet AG and Bell PB (1996a) Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DiSC assay methodology. Leuk Res 20: 143-153
7. Bosanquet AG and Bell PB (1996b) Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in chronic lymphocytic leukaemia. Blood 87: 1962-1971
8. Bosanquet AG, McCann SR, Crotty GM, Mills MJ and Catovsky D (1995) Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay. Acta Haematol 93: 73-79
9. Boyd MR and Paull KD (1995) Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Develop Res 34: 91-109
10. Buraczewska I, Szumiel I, Zagorski S and Afanasjev GG (1994) Effects of 8-chloroadenosine-3′,5′-monophosphate in combination with irradiation in L5178Y mouse lymphoblasts. Acta Oncol 33: 671-675
11. Carmichael J (1994) Cancer chemotherapy: identifying novel anticancer drugs. Br Med J 308: 1288-1290
12. Cho-Chung YS and Clair T (1993) The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases. Pharmacol Ther 60: 265-288
13. Cummings J, Leonard RC and Miller WR (1994) Sensitive determination of 8-chloroadenosine 3′,5′-monophosphate and 8-chloroadenosine in plasma by high performance liquid chromatography. J Chromatogr B Biomed Appl 658: 183-188
14. Fruehauf JP and Bosanquet AG (1993) In vitro determination of drug response: a discussion of clinical applications. PPO Updates 7 (December): 1-16
15. Gazdar AF, Steinberg SM, Russell EK, Linnoila RI, Oie HK, Ghosh BC, Cotelingham JD, Johnson BE, Minna JD and Ihde DC (1990) Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial. J Natl Cancer Inst 82: 117-124
16. Glazer RI and Rohlff C (1994) Transcriptional regulation of multidrug resistance in breast cancer. Breast Cancer Res Treat 31: 263-271
17. Hanzuske A-R, Wüster KC, Lehmer A, Rotter M, Schneider P, Kaeser-Fröhlich A, Rastetter J and Depenbrock H (1995) Activity of NK 611, a new epipodophyllotoxin derivative, against colony forming units from freshly explanted human tumours in vitro. Eur J Cancer 31: 1677-1681
18. Harland SJ, Newell DR, Siddik ZH, Chadwick R, Calvert AH and Harrap KR (1984) Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function. Cancer Res 44: 1693-1697
19. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E and Warnke RAA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84: 1361-1392
20. Lange-Carter CA, Vuillequez JJ and Malkinson AM (1993) 8-Chloroadenosine mediates 8-chloro-cyclic AMP-induced down-regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism. Cancer Res 53: 393-400
21. Langeveld CH, Jongenelen CA, Heimans JJ and Stoof JC (1992a) Growth inhibition of human glioma cells induced by 8-chloroadenosine, an active metabolite of 8-chloro-cyclic adenosine 3′,5′-monophosphate. Cancer Res 52: 3994-3999
22. Langeveld CH, Jongenelen CA, Heimans JJ and Stoof JC (1992b) 8-Chloro-cyclic adenosine monophosphate, a novel cyclic AMP analog that inhibits human glioma cell growth in concentrations that do not induce differentiation. Exp Neurol 117: 196-203
23. Larsson R, Fridborg H, Liliemark J, Csoka K, Kristensen J, De La Torre M and Nygren P (1994) In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours. Eur J Cancer 30A: 1022-1026
24. Martin KJ, Chen S-F, Clark GM, Degen D, Wajima M, Von Hoff DD and Kaddurah-Daouk R (1994) Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells. J Natl Cancer Inst 86: 608-613
25. Nagourney RA, Evans SS, Messenger JC, Zhuang SUY and Weisenthal LM (1993) 2-chlorodeoxyadenosine activity and cross-resistance patterns in primary cultures of human hematologic neoplasms. Br J Cancer 67: 10-14
26. Nishio K, Morikage T, Kubota N, Ohmori T, Takeda Y, Fujiwara Y, Miki K, Abe K and Saijo N (1992) Alteration of type II regulatory subunit of cAMP-dependent protein kinase in human cisplatin-resistant cells as a basis of collateral sensitivity to 8-chloro-cAMP. Jpn J Cancer Res 83: 754-760
27. North PS, Davies SL, Ciardiella F, Damiano V, Bianco C, Pepe S, Bianco AR, Harris AL, Hickson ID and Tortora G (1994) Overexpression of the RI alpha subunit of protein kinase A confers hypersensitivity to topoisomerase II inhibitors and 8-chloro-cyclic adenosine 3′,5′-monophosphate in Chinese hamster ovary cells. Cancer Res 54: 4123-4128
28. Pinto A, Aldinucci D, Gattei V, Zagonel V, Tortora G, Budillon A and Cho-Chung YS (1992) Inhibition of the self-renewal capacity of blast progenitors from acute myoblastic leukemia patients by site-selective 8-chloroadenosine 3′,5′-cyclic monophosphate. Proc Natl Acad Sci USA 89: 8884-8888
29. Reece PA, Bishop JF, Olver IN, Stafford I, Hillcoat BL and Morstym G (1987) Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinoma. Cancer Chemother Pharmacol 19: 326-330
30. Rohlff C, Clair T and Cho-Chung YS (1993a) 8-Cl-cAMP induces truncation and down-regulation of the RIα subunit and up-regulation of the RIIβ subunit of cAMP dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells. J Biol Chem 268: 5774-5782
31. Rholff C, Safa B, Rahman A, Cho-Chung YS, Klecker RW and Glazer RI (1993b) Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities. Mol Pharmacol 43: 372-379
32. Saunders MP, Salisbury AJ, Harris AL, Long L, O'Byrne KJ, Macaulay VM, Miki K, Cho-Chung YS and Talbot DC (1995) Phase I study of the protein kinase A regulator 8-chloro cyclic AMP. Proc Am Assoc Cancer Res 36: 241
33. Scala S, Budillon A, Zhan Z, Cho-Chung YS, Jefferson J, Tsokos M and Bates SE (1995) Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. J Clin Inv 96: 1026-1034
34. Taylor CW and Yeoman LC (1992) Inhibition of colon tumor cell growth by 8-chloro-cAMP is dependent upon its conversion to 8-chloro-adenosine. Anticancer Drugs 3: 485-491
35. Tidefelt U, Sundman-Engberg B, Rhedin A-S and Paul C (1989) In vitro drug testing in patients with acute leukemia with incubations mimicking in vivo intracellular drug concentrations. Eur J Haematol 43: 374-384
36. Tortora G, Ciardiello F, Pepe S, Tagliaferri P, Ruggiero A, Bianco C, Guarrasi R, Miki K and Raffaele Bianco A (1995) Phase I clinical study with 8-Cl-cAMP and evaluation of immunological effects in cancer patients. Clin Cancer Res 1: 377-384
37. Vandenberghe E (1994) Mantle cell lymphoma. Blood Rev 8: 79-87
38. Van-Lookeren-Campagne MM, Villalba-Diaz F, Jastorff B and Kessin RH (1991) 8-Chloroadenosine 3′,5′-monophosphate inhibits the growth of Chinese hamster ovary and Molt-4 cells through its adenosine metabolite. Cancer Res 51: 1600-1605
39. Weisenthal LM (1991) Predictive assays for drug and radiation resistance. In Human cancer in primary culture: A handbook, Masters JRW (ed.), pp. 103-147. Kluwer Academic: Dordrecht
40. Weisenthal LM (1992) Antineoplastic drug screening belongs in the laboratory, not in the clinic. J Natl Cancer Inst 84: 466-469
41. Weisenthal LM and Kern DH (1991) Prediction of drug resistance in cancer chemotherapy: the Kern and DiSC assays. Oncology 5: 93-103
42. Yokozaki H, Budillon A, Clair T, Kelley K, Cowan KH, Rohlff C, Glazer RI and Cho-Chung YS (1993) 8-Chloroadenosine 3′-5′-monophosphate as a novel modulator of multidrug resistance. Int J Oncol 3: 423-430